bioRxivMicrobiologyPreprint
Genomic insights into six clinical isolates of Stenotrophomonas maltophilia from Northern India
Nazneen GheewallaiD, Yuvraj Jadhav, Jaisri Jagannadham, Akansha TyagiiD, Sandeep BudhirajaiD, Bansidhar TaraiiD, Shraddha Madhav KarveiD
Abstract
Stenotrophomonas maltophilia is a gram-negative opportunistic pathogen that causes respiratory, urinary and bloodstream infections. Due to rising prevalence of difficult to treat S. maltophilia infections, it is considered as one of the important pathogens in many regions, including India. Despite its importance in public health, very few studies provide detailed characterization of the genomes of clinical isolates of S. maltophilia. In this study, we sequence six isolates of S. maltophilia from a tertiary healthcare centre in the Northern India. Along with the culture sensitivity, we report the genomic underpinnings of resistance and virulence in these isolates. In three out of six isolates, we identify a rare beta-lactamase gene kbl-1 that can confer resistance to variety of beta-lactam antibiotics. Though truncated in two isolates, an intact copy of kbl-1 is present in the third isolate. This intact copy of kbl-1 is flanked by insertion elements that are commonly found in several pathogenic species indicating high potential for horizontal gene transfer. To the best of our knowledge, this is a first report of kbl-1 in S. maltophilia from India. ImportanceAntimicrobial resistance (AMR) is one of the biggest global public health challenges. Tackling AMR gets complicated as diverse pathogenic species are involved and resistance is manifested against several different kinds of antibiotics. Genomic surveillance of the resistant pathogens is a key to fight this global threat and needs to extend to important emerging pathogens as well. Here we report genomic sequences and associated characteristics of six Stenotrophomonas maltophilia isolates from Northern India. Along with several resistance and virulence genes we also discover a rare beta-lactamase, blaKBL-1, gene with a high potential of transfer to other species. blaKBL-1 beta-lactamase confers resistance to several beta-lactam antibiotics like ampicillin, amoxicillin, penicillin G, piperacillin, ceftazidime and cefozopran. This is the first report of the presences of this beta-lactamase from India.
- organism: bacteria (other)
- assay: whole-genome sequencing
- research focus: variant calling
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- First worldwide detection of blaIMP-15 in Stenotrophomonas maltophilia isolated from a patient in Lebanon.
Ziad C. Jabbour, Jose-Rita Gerges, … Antoine G. Abou Fayad·bioRxiv·Feb 28, 2025
- Extreme genome selection towards complete antimicrobial resistance in a nosocomial strain of Stenotrophomonas maltophilia complex
Sanjeet Kumar, Kanika Bansal, … Prabhu B. Patil·GenomicsPeer-reviewed·Jul 9, 2020
- The global phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
Matthias I. Gröschel, Conor Joseph Meehan, … Thomas Andreas Kohl·Nature CommunicationsPeer-reviewed·Apr 27, 2020
- Clonal transmission and new mechanism of resistance to trimethoprim-sulfamethoxazole in Stenotrophomonas maltophilia strains isolated in a neonatology unit at Antananarivo, Madagascar, deciphered by whole genome sequence analysis
M. A. N. Rabenandrasana, V. Andrianoelina, … J. M. Collard·bioRxiv·Jul 10, 2019
- TonB dependent uptake of β-lactam antibiotics in the opportunistic human pathogen Stenotrophomonas maltophilia.
K. Calvopina, P. Dulyayangkul, … M. Avison·bioRxiv·Apr 22, 2019
- Comparative genomics of clinical Stenotrophomonas maltophilia isolates reveals regions of diversity which correlate with colonization and persistence in vivo
M. S. McDaniel, N. A. Sumpter, … W. E. Swords·bioRxiv·Jul 14, 2023